Search results
Results From The WOW.Com Content Network
Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...
Pfizer: Off-label promotion of Bextra, Geodon, Zyvox and Lyrica, September 2009. In what was the largest pharmaceutical settlement in U.S. history at the time, Pfizer reached a $2.3 billion settlement with the Department of Justice to resolve criminal charges and civil claims under the False Claims Act.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...
Nilotinib, sold under the brand name Tasigna marketed worldwide by Novartis, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. [4] It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib. [4] [5] It is taken ...
August 7, 2024 at 2:23 PM. By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of ...
One of the largest publications in America is denying a report that its preparing to lay off hundreds of staffers.
Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [ 1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [ 2] Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and ...
It is Novartis' proprietary adjuvant that is added to influenza vaccines to help stimulate the human body's immune response through production of CD4 memory cells. [1] [2] [3] MF59 is the first oil-in-water influenza vaccine adjuvant to be commercialized in combination with a seasonal influenza virus vaccine.